Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Revenue
Product sales	$ 1,550,845	$ 830,880
Licensing revenue	609,167	5,000
Total revenue	2,160,012	835,880
Cost of product sales	1,034,528	346,129
Gross profit	1,125,484	489,751
Operating expenses
Research and development	105,968	116,521
Sales and marketing	202,758	73,381
General and administrative	624,427	479,113
Total operating expenses	933,153	669,015
Operating income (loss)	192,331	(179,264)
Other income (expenses)
Other income		88,272
Interest expense	(185,555)	(178,777)
Amortization of deferred financing costs	(13,952)	(27,045)
Loss on disposal of property and equipment		(63)
Total other income (expenses)	(199,507)	(117,613)
Net Loss	$ (7,176)	$ (296,877)
Basic and diluted net loss per common share	$ 0.00	$ 0.00
Basic and diluted weighted average common shares used to calculate net loss per common share	69,873,598	69,679,854